Dengue Literature Review

Cytokine Storm

6 min read

Cytokine Storm

Overview

Cytokine storm in dengue refers to the excessive and dysregulated release of pro-inflammatory and immunomodulatory cytokines during acute infection, particularly in severe dengue (DHF/DSS). It is one of several converging mechanisms — alongside ADE, autoantibody-mediated damage, and direct NS1 effects — that drive vascular permeability, thrombocytopenia, and coagulopathy. The term encompasses a complex network of mediators including IL-10, TNF-alpha, IFN-alpha, IL-6, IL-8, MCP-1, MIF, and MMP-9, each with distinct cellular sources and downstream effects.

Importantly, cytokine storm is not a single mechanism but a downstream consequence of multiple upstream triggers: ADE-enhanced viral replication in FcR-bearing cells, T cell overactivation via original antigenic sin, NS1-TLR4 signalling, and bystander innate immune activation. These pathways feed into each other, making the relative contribution of each difficult to dissect.

Key Points from Literature

Key cytokines and their roles

IL-10

IL-10 is the cytokine most consistently associated with dengue severity in this wiki’s sources:

IFN-alpha (Type I Interferon)

TNF-alpha

Other mediators

NS1-TLR4 as a direct cytokine trigger

Soluble NS1 (sNS1) activates TLR4 on macrophages and PBMCs — analogous to LPS/endotoxin recognition — triggering pro-inflammatory cytokine release independently of antibodies. This mechanism can operate in primary infection before anti-NS1 Abs are generated and may be the earliest trigger of the cytokine cascade (see Guzman2016 - Dengue Infection, NS1 Protein, Dengue Pathophysiology).

Bystander activation and polyclonal immune stimulation

Cytokine storm can drive non-specific polyclonal B and T cell activation (bystander activation): IFN-alpha/gamma, IL-1, IL-6, and TNF released during infection activate plasmacytoid dendritic cells, which in turn drive polyclonal B cell activation and transient autoantibody production (see Johnson2022 - Infectious Diseases Autoantibodies and Autoimmunity, Infection-Triggered Autoimmunity). However, the COVID-19 comparison (Trahtemberg et al., cited in Johnson2022) found no significant ANA difference between COVID-19-positive and -negative ICU patients — suggesting bystander activation from severe cytokine storm alone is insufficient to consistently elevate ANA.

Original antigenic sin amplifies cytokine production

In secondary heterotypic infection, low-affinity memory T cells from the primary infection expand selectively (original antigenic sin). These cross-reactive T cells produce inflammatory cytokines (TNF-alpha, IFN-gamma) that drive plasma leakage, but clear the new serotype inefficiently — a proposed mechanism for why secondary infection is more severe (see Wan2012 - Autoimmunity in Dengue Pathogenesis, Original Antigenic Sin, T Cell Responses in Dengue).

Temporal dynamics

The cytokine cascade follows a characteristic time course:

  • Cytokine accumulation occurs throughout the febrile phase
  • Vascular permeability peaks at defervescence, not during peak viraemia — suggesting threshold-dependent cytokine-mediated effects rather than direct viral cytopathology (see Dengue Pathophysiology)
  • Resolution is typically rapid (24-36 hours in non-fatal cases), consistent with a reversible soluble-mediator mechanism rather than structural endothelial damage

Contradictions & Debates

  • Cause vs. consequence: Elevated cytokines in severe dengue may be driving pathology or may be markers of a more vigorous but ultimately appropriate immune response to higher intracellular viral loads (from ADE). Sungnak2025 matched viremia across severity groups, partially addressing this — but intracellular viral burden in tissue-resident macrophages is not captured by plasma viremia measurement.
  • IFN-alpha paradox: IFN-alpha is essential for antiviral defence, yet elevated in severe disease. Whether the problem is too much IFN-alpha, the wrong timing, or an ADE-amplified IFN response to endosomally delivered viral RNA remains unresolved (see Type I Interferon Response in Dengue).
  • IL-10: pathogenic or regulatory? IL-10 is conventionally anti-inflammatory, yet consistently elevated in severe dengue. In the intrinsic ADE model, IL-10 suppresses Th1 clearance while driving antibody (and potentially ADE-capable Ab) production — a context-dependent pathogenic role.
  • Multiple competing models: NS1-TLR4, T cell-mediated cytokine release, ADE-amplified innate sensing, and anti-NS1 autoantibody-mediated NF-kappaB activation all converge on cytokine production. No single pathway accounts for all observations, and their relative contributions likely vary by infection sequence, host genetics, and viral genotype.

Sources

Graph View

Backlinks